-
1.
公开(公告)号:US20220088144A1
公开(公告)日:2022-03-24
申请号:US17422193
申请日:2020-01-13
Applicant: UNIVERSITÄTSSPITAL BASEL
Inventor: Marc DONATH
IPC: A61K38/20 , A61K31/7048 , A61K31/7042 , A61K31/351 , A61K31/382 , C07K16/24 , C07K16/28 , A61P3/08
Abstract: The present invention relates to the use of SGLT-2 inhibitors and/or an interleukin-1-receptor antagonist or a non-agonist antibody reactive to IL-1 or IL-1R in the treatment of prevention of symptomatic hypoglycaemia after bariatric surgery.